AU2002230768A1 - In vitro synthesis of a layered cell sorted tissue - Google Patents

In vitro synthesis of a layered cell sorted tissue

Info

Publication number
AU2002230768A1
AU2002230768A1 AU2002230768A AU3076802A AU2002230768A1 AU 2002230768 A1 AU2002230768 A1 AU 2002230768A1 AU 2002230768 A AU2002230768 A AU 2002230768A AU 3076802 A AU3076802 A AU 3076802A AU 2002230768 A1 AU2002230768 A1 AU 2002230768A1
Authority
AU
Australia
Prior art keywords
tissue
cell
vitro
layered cell
cell sorted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002230768A
Inventor
Deborah Finlay
Warren K. Hoeffler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xgene Corp
Original Assignee
Xgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xgene Corp filed Critical Xgene Corp
Publication of AU2002230768A1 publication Critical patent/AU2002230768A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698—Skin equivalents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/30—Coculture with; Conditioned medium produced by tumour cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/04—Screening or testing on artificial tissues
    • C12N2503/06—Screening or testing on artificial skin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Abstract

The present invention relates to a layered cell sorted tissue that is formed in vitro. The tissue is generated by the spontaneous sorting of cells from a homogenous cell mixture into discrete layers by cell type. Connective tissue components, such as fibronectin, may be used to manipulate orientation of the layers during the cell sorting process. The layered cell sorted tissue may be used as a skin graft for burns, wounds, and ulcers. The tissue may also be used in assays to determine effects of chemicals or drugs on human tissue in vitro as well as provide an in vitro assay for tumor cell metastasis.
AU2002230768A 2000-12-08 2001-12-07 In vitro synthesis of a layered cell sorted tissue Abandoned AU2002230768A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25478100P 2000-12-08 2000-12-08
US60254781 2000-12-08
PCT/US2001/047928 WO2002046375A1 (en) 2000-12-08 2001-12-07 In vitro synthesis of a layered cell sorted tissue

Publications (1)

Publication Number Publication Date
AU2002230768A1 true AU2002230768A1 (en) 2002-06-18

Family

ID=22965565

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002230768A Abandoned AU2002230768A1 (en) 2000-12-08 2001-12-07 In vitro synthesis of a layered cell sorted tissue

Country Status (6)

Country Link
US (2) US6815202B2 (en)
EP (1) EP1339831B1 (en)
AT (1) ATE354640T1 (en)
AU (1) AU2002230768A1 (en)
DE (1) DE60126815T2 (en)
WO (1) WO2002046375A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY137139A (en) * 2004-06-29 2008-12-31 Univ Kebangsaan Malaysia Formation of tissue engineered human skin using hpd as biomaterials
GB2442271B (en) * 2006-09-27 2011-06-15 Denis Eon Solomon An in vitro human skin assay protocol which directly uses the natural cellular interactions between un-manipulated autologous human epidermal and dermal cells
US8105380B2 (en) * 2006-10-23 2012-01-31 Stemedica Cell Technologies, Inc. Cellular scaffold
US8709081B2 (en) 2006-10-23 2014-04-29 Stemedica Cell Technologies, Inc. Cellular scaffold
WO2008138000A1 (en) * 2007-05-08 2008-11-13 Xgene Corporation Spongy epithelial cell scaffold for vascularizing wounds
WO2011160055A2 (en) * 2010-06-18 2011-12-22 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Hair follicle neogenesis
US10478526B2 (en) 2013-05-03 2019-11-19 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Skin substitutes and methods for hair follicle neogenesis
KR101673424B1 (en) * 2015-11-13 2016-11-07 호서대학교 산학협력단 Protecting apparatus for preventing from volatilization of apply matter and external stimulus
GB201715929D0 (en) * 2017-09-30 2017-11-15 Upside Biotechnologies Ltd Method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5988423A (en) * 1982-11-09 1984-05-22 Nippon Chem Res Kk Production of human tomorous cell degeneration factor (tdf)
EP0929661A4 (en) * 1995-11-15 2000-01-12 Univ Utah Novel method of culturing human epithelial cells for the identification of cancer therapeutics and diagnostics
US20010048917A1 (en) * 1998-03-09 2001-12-06 Warren Hoeffler Skin equivalent and methods of forming and using same

Also Published As

Publication number Publication date
US20050118146A1 (en) 2005-06-02
ATE354640T1 (en) 2007-03-15
US20020120950A1 (en) 2002-08-29
WO2002046375A1 (en) 2002-06-13
US6815202B2 (en) 2004-11-09
DE60126815D1 (en) 2007-04-05
EP1339831B1 (en) 2007-02-21
DE60126815T2 (en) 2007-11-15
EP1339831A1 (en) 2003-09-03

Similar Documents

Publication Publication Date Title
UA81398C2 (en) Keratinocytes which may be used as biologically active substances for the treatment of wounds
ATE271606T1 (en) ACTIVATION OF RECEPTORS BY GAS6
AR018023A1 (en) PROCEDURE FOR THE MANUFACTURE OF POLYPEPTIDES WITH APPROPRIATE GLYCOSILATION
GB2335194A (en) Notch
PA8464901A1 (en) PROCESSES FOR THE SYNTHESIS OF 1,3-DIOLES
DE69435096D1 (en) COMPOSITION FOR IN VIVO PRODUCTION OF THERAPEUTIC PRODUCTS
DE60132498D1 (en) Isoprenoidproduktion
AU4304196A (en) Novel sulfonamides
AU2002230768A1 (en) In vitro synthesis of a layered cell sorted tissue
FR15C0055I1 (en)
ATE213164T1 (en) USE OF NONA- AND DECAPEPTIDES FOR PRODUCING A MEDICINAL PRODUCT TO FIGHT AIDS
DE59903410D1 (en) HYBRID PROTEIN TO INHIBIT MAST CELL DEGRANULATION AND USE
AU1096595A (en) Thrombin mutants
WO2002002783A3 (en) Expression vectors
BG103096A (en) Thrombin inhibitors
ECSP930917A (en) POLYESTER FIBER AND PROCEDURE FOR ITS PRODUCTION
Bekeschus et al. The feed gas composition determines the degree of physical plasma-induced platelet activation for blood coagulation
BR9809284A (en) Construct and process for high-level polynucleotide expression
TR200001486T2 (en) Using a mixture of diol and alpha-hydroxy acid for the treatment of skin diseases with hyperkeratosis
ES2061863T3 (en) NEW QUINOLYLOXAZOL-2-ONAS USEFUL AS PROTEIN QUINASE C INHIBITORS.
MXPA02010643A (en) A method of treating soy proteins and a soy protein product produced by this method.
DE60226896D1 (en) PREPARATION OF F (AB ') 2 FRAGMENTS IN TISSUE CELL
IL187595A0 (en) Antitumor antibodies, proteins, and uses thereof
AR018263A1 (en) AN APPROPRIATE MIX FOR A PACKING SHEET AND A LAMINATED STRUCTURE FOR THE SAME
BR0116222A (en) Method for producing a high unbraided fabric laminate and laminate thereof